Who is covered by the GoodRx privacy settlement?

The proposed settlement class is all natural persons in the United States who used any website, app, or service made available by or through GoodRx at any time prior to April 20, 2024. GoodRx Gold, GoodRx Care, and HeyDoctor users are included. GoodRx and its affiliates, Meta, Google, the opt-outs, and the presiding judges are excluded.

Can I file a claim now?

Not yet. As of June 2026 the settlement is awaiting preliminary approval from the court. No claim form is open and no deadlines are set. If the court grants preliminary approval, notice will go out and a claim window will open at the official settlement website. The claim deadline is set at 60 days after the notice date.

Will I need to prove anything to file?

Based on the proposed claim form, a claimant attests under penalty of perjury that they resided in the United States and used a GoodRx website, app, or service before April 20, 2024, and chooses a payment method (PayPal, Venmo, Zelle, a virtual prepaid card, or a mailed check). Mailed notices will include a Claimant Code and Confirmation Code. Final claim requirements are set once the court approves the notice.

How will I know when I can file a GoodRx settlement claim?

If the court grants preliminary approval, a settlement administrator will email notice to GoodRx users it can identify and launch the official settlement website with the claim form and deadlines. You can also check back here for updates on the schedule.

GoodRx $32M Privacy Settlement 2026: Who Qualifies

Q: How much is the GoodRx settlement?

GoodRx and Criteo agreed to pay a non-reversionary $32,000,000 into a settlement fund. After notice and administration costs, taxes, court-approved attorneys' fees and expenses, and service awards are deducted, the remaining net fund is divided pro rata (an equal share) among everyone who files a valid, timely claim.

Q: What about Meta and Google?

This settlement resolves the case only against GoodRx and Criteo. The plaintiffs' claims against Meta Platforms and Google continue in the same litigation, so those defendants are not part of this $32 million deal.

Q: Is the GoodRx settlement legitimate?

Yes, it is a real proposed class action settlement in Jane Doe et al. v. GoodRx Holdings, Inc., No. 3:23-cv-00501-AMO, in the U.S. District Court for the Northern District of California. It still needs the court's preliminary and final approval before any money is paid. Be cautious of unsolicited texts or emails asking for payment or bank logins — the official settlement website is the only place to file.

Q: What is the GoodRx settlement claim deadline?

No deadline is set yet because the settlement is still awaiting preliminary approval. Under the agreement, once notice goes out the claim deadline, opt-out deadline, and objection deadline all fall 60 days after the notice date. The exact dates will be posted on the official settlement website when the claim period opens.

By Steve Levine

GoodRx telehealth and prescription app on a smartphone

Published: June 16, 2026

Status Proposed Settlement · Awaiting Preliminary Approval

Settlement Fund $32,000,000 Non-reversionary · paid by GoodRx and Criteo · divided pro rata among valid claims

Who's Covered U.S. GoodRx users before April 20, 2024 Anyone who used a GoodRx website, app, or service — including GoodRx Gold, GoodRx Care, and HeyDoctor

Can I Claim? Not yet — no claim form is open A claim window opens only if the court grants preliminary approval; deadline set at 60 days after notice

What Is This About?

GoodRx Holdings, Inc. and advertising-technology firm Criteo Corp. have agreed to pay $32 million to resolve a privacy class action over how GoodRx handled its users' sensitive health information. The case is captioned Jane Doe et al. v. GoodRx Holdings, Inc., et al., No. 3:23-cv-00501-AMO, in the U.S. District Court for the Northern District of California. The amended settlement agreement was signed November 19, 2025, and the settlement papers were filed with the court on June 1, 2026. As of this writing, the settlement is awaiting the court's preliminary approval, so there is nothing to claim yet.

GoodRx is a telehealth and prescription-coupon company used by millions of people each month for discount coupons, telehealth visits, and other health services. The plaintiffs allege that, when people used GoodRx, the company collected personal and health information — including details about their prescriptions and health conditions, email addresses, and phone numbers — and then disclosed that data to advertising and analytics companies through tracking technologies embedded on the GoodRx platform. Those technologies included standard JavaScript pixels, software development kits (SDKs), cookies, and application programming interfaces (APIs) provided by Criteo, Meta Platforms, and Google. The plaintiffs further allege that the third parties used the information for their own advertising purposes.

GoodRx and Criteo deny the allegations and deny that they violated any law. They agreed to settle to avoid the expense and uncertainty of continued litigation. A settlement is a compromise; it is not a finding or admission of wrongdoing by either company.

The Allegations

The consolidated complaint asserts a range of privacy and consumer-protection claims, including intrusion upon seclusion, unjust enrichment, negligence, and violations of the California Confidentiality of Medical Information Act (CMIA), the California Invasion of Privacy Act (CIPA), the California Consumers Legal Remedies Act (CLRA), California's Unfair Competition Law (UCL), New York's General Business Law, and the Illinois Consumer Fraud and Deceptive Business Practices Act. According to the plaintiffs, much of the alleged data sharing occurred roughly between 2017 and 2020.

The lawsuit followed a February 1, 2023 enforcement action by the Federal Trade Commission, which alleged GoodRx shared users' personal and health information with third parties in violation of the FTC Act and the agency's Health Breach Notification Rule. That FTC matter — the first enforcement action ever brought under the Health Breach Notification Rule — is separate from this private class action and this settlement.

What the Settlement Provides

Under the proposed deal, GoodRx and Criteo will pay a combined, non-reversionary $32,000,000 into a settlement fund. "Non-reversionary" means no unclaimed money goes back to the companies once the settlement takes effect. The fund pays for settlement notice and administration, taxes, court-approved attorneys' fees and expenses, and service awards for the class representatives; whatever remains — the net settlement fund — is split pro rata, meaning each person who files a valid, timely claim receives an equal share. The exact per-person amount will depend on how many people file.

The proposed claim form lets class members choose how to be paid: PayPal, Venmo, Zelle, a virtual prepaid card, or a mailed paper check. Class members will be able to file online or by mail once the claim period opens.

Class Counsel have said they will ask the court to approve attorneys' fees of up to one-third of the fund (about $10.67 million) plus litigation expenses, and service awards of up to $2,000 for each named plaintiff. The court decides those amounts separately from whether it approves the settlement itself.

Who Is in the Settlement Class?

The proposed settlement class is all natural persons in the United States who used any website, app, or service made available by or through GoodRx at any time prior to April 20, 2024. That includes the main GoodRx website and app as well as GoodRx Gold, GoodRx Care, and HeyDoctor. Excluded from the class are GoodRx and its affiliates, officers, and directors; Meta and Google; the people who opt out; and the judges presiding over the case and their staff.

What About Meta and Google?

This settlement resolves the case only as to GoodRx and Criteo. The plaintiffs' claims against Meta Platforms and Google — the two "Remaining Defendants" — are not part of this $32 million agreement and continue in the same litigation. In other words, a separate resolution or trial involving Meta and Google could still follow.

What Happens Next

The next step is the court's decision on preliminary approval. If the court grants it, a court-appointed settlement administrator will send notice to class members (largely by email), launch the official settlement website, and open the claim window. Under the agreement, notice goes out within 45 days of preliminary approval, and the claim deadline, opt-out deadline, and objection deadline are all set at 60 days after that notice date. A final approval hearing would be scheduled at least 150 days after preliminary approval.

When Will the Claim Form Be Available? (Estimate)

There is no claim form yet, and no firm date — the timeline only starts once the court grants preliminary approval, which had not happened as of June 2026. Using the deadlines written into the settlement agreement, here is the rough sequence to expect:

Preliminary approval — the trigger. Everything below is measured from this date.
Notice + claim form go live — within 45 days after preliminary approval. This is when the official settlement website opens and class members can start filing.
Claim deadline — 60 days after the notice date (so roughly 90–105 days after preliminary approval). Opt-out and objection deadlines fall on the same 60-day mark.
Final approval hearing — at least 150 days after preliminary approval.
Payments — issued within 45 days after the settlement's "effective date," which only arrives after final approval and the passing of any appeal period.

In plain terms: if a court grants preliminary approval, the claim form would typically open within about a month and a half, and the window to file would stay open for roughly two months after that. These are estimates based on the agreement's timetable, not court-ordered dates — the exact schedule is set by the judge and posted on the official settlement website. We'll update this page with the real claim-open date and deadline as soon as they're announced.

The official settlement website is expected to be GoodRxPrivacySettlement.com, which will post the notice, claim form, and key dates once the case reaches that stage. Until then, there is no claim form to fill out and no deadline to meet. We'll update this page as the schedule is set.

This privacy case is part of a broader wave of health-app data-sharing class actions. For a settlement that has already opened, see our coverage of the Flo period-tracker privacy settlement, which raised similar pixel- and SDK-based data-sharing claims.

Frequently Asked Questions

Is there anything to claim right now?
No. The settlement is awaiting preliminary approval as of June 2026. No claim form is open and no deadlines are set yet.

How much will each person get?
It isn't known yet. The net fund is split equally among everyone who files a valid claim, so the per-person payment depends on the number of claims.

Will I have to upload receipts or records?
Based on the proposed claim form, the main requirement is a sworn attestation that you used a GoodRx website, app, or service in the U.S. before April 20, 2024, plus your payment choice. Mailed notices will carry a Claimant Code and Confirmation Code. Final requirements are set when the court approves the notice.

Does this affect my claims against Meta or Google?
No. The release in this settlement covers GoodRx and Criteo only. The case against Meta and Google continues.

Is the GoodRx settlement legitimate?
Yes — it's a real proposed settlement in Jane Doe et al. v. GoodRx Holdings, Inc., No. 3:23-cv-00501-AMO (N.D. Cal.), still subject to court approval. When the claim period opens, file only through the official settlement website. Treat any unsolicited message asking for payment or bank logins as a red flag.

What is the GoodRx settlement claim deadline?
None is set yet. Once notice goes out, the claim, opt-out, and objection deadlines all land 60 days after the notice date. The official settlement website will post the exact dates when claims open.

How will I know when I can file?
If the court grants preliminary approval, a settlement administrator will email notice to identifiable GoodRx users and launch the official settlement website with the claim form and deadlines. You can also check back here for updates.

Sources

Amended Class Action Settlement Agreement and Release, Jane Doe et al. v. GoodRx Holdings, Inc., et al., No. 3:23-cv-00501-AMO (N.D. Cal.), filed June 1, 2026 (ECF No. 357-2).
Consolidated Class Action Complaint, Jane Doe et al. v. GoodRx Holdings, Inc., et al., No. 3:23-cv-00501-AMO (N.D. Cal.), filed May 26, 2023.
U.S. Federal Trade Commission press release and complaint, FTC v. GoodRx Holdings, Inc. (Feb. 1, 2023).